ScinoPharm Taiwan Market Cap

ScinoPharm Taiwan has a market cap or net worth of 16.29 billion as of March 9, 2026. Its market cap has decreased by -8.65% in one year.

Market Cap

16.29B

Enterprise Value

13.94B

Revenue

3.16B

Ranking

n/a

PE Ratio

121.18

Stock Price

20.60

Market Cap Chart

Since October 29, 2010, ScinoPharm Taiwan's market cap has decreased from 30.44B to 16.29B, a decrease of -46.48%. That is a compound annual growth rate of -3.99%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	16.29B	22.99%
Dec 31, 2025	13.24B	-24.04%
Dec 31, 2024	17.44B	-16.48%
Dec 29, 2023	20.88B	3.73%
Dec 30, 2022	20.12B	3.25%
Dec 30, 2021	19.49B	-14.56%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Grape King Bio	17.85B
Synmosa Biopharma	15.92B
YungShin Global Holding	14.46B
TTY Biopharm Company	20.74B
Foresee Pharmaceuticals	12.86B
Alar Pharmaceuticals	12.83B
Handa Pharmaceuticals	12.55B
Standard Chemical & Pharmaceutical	11.54B

Market Cap Rankings